- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
COVID 19 associated sinus bradycardia effectively treated by Theophylline - Video
Overview
Theophylline is popularly used to treat most of breathing disorders like wheezing, shortness of breath etc, Covid-19 is known to cause the same in patients, its efficacy has been evaluated ever since. However breathing disorders with Covid-19 greatly affect quality of life.
The findings, published in the Journal of the Association of Physicians of India (JAPI) showed that sinus bradycardia due to COVID-19 is usually transient and responds well to this drug. A short course of oral etophylline and theophylline prolonged-release tablet (150 mg) could be used for treating sinus bradycardia due to COVID-19 in the future, the study suggested.
The drug was safer than other modalities for the treatment of sinus node dysfunction associated with COVID-19. However, researchers feel the need for strict monitoring and larger studies to assess the benefit-risk balance of the addition of this drug.
"COVID-19 virus directly involves the myocardium by entering the cardiac myocytes resulting in inflammation and injury," wrote the authors. "As the sinus bradycardia due to COVID-19 is usually transient and responds well to this drug, a short course of the drug could be added to treat this arrhythmia in future."
For more information check out the full story on the link below:
Theophylline, potential drug for treating COVID-19 associated sinus bradycardia: Study
Speakers
Dr. Nandita Mohan
BDS, MDS( Pedodontics and Preventive Dentistry)